| Outcome Measures: |
Primary: Renal Function, Maintain or improve renal function \[Creatinine clearance and Proteinuria\] by ≥ 20% , as measured by eGFR or 24 hour urine study., 6 months | Secondary: Hyperparathyroidism, Change in serum parathyroid hormone levels, 6 months|Anemia, Change in hemoglobin levels, 6 months|Inflammatory blood markers, Change in serum C-Reactive Protein and Creatine Kinase, 6 months|Vitamin D uptake, Change in Vitamin D dosing requirements, 6 months|Hypercalcemia, Change in serum calcium levels, 6 months|Phosphate, Change in serum phosphate levels, 6 months|Total Iron Binding Capacity, Change in Total Iron Binding Capacity in serum, 6 months|Epogen Dose, Change in epogen dosing requirements, 6 months|Fall risk, Timed Up and Go Test will improve, 6 months|Walking endurance, 2 minute walk distance, 6 months|Gait speed, 10 meter gait speed test, 6 months|Mobility disablement risk, Short Performance Physical Battery, 6 months|Habitual Physical Activity, Physical Activity Scale for the Elderly, 6 months|Calf Strength, Heel Rise Test, 6 months|Quality of life, Medical Outcome Study Short Form 36, 6 months|Fear of Falling, ABC Scale \[Activities-specific Balance Confidence Scale-Powell\]. Scores to be above 67., 6 months|Self- Report Physical Activity, RAPA \[Rapid Assessment of Physical Activity-Univ of Washington\], 6 months|Nutritional Status, Body Mass Index, 6 months|Lean body mass, Body Composition examination using Noori (2012) regression equation for lean body mass., 6 months|Caloric intake, Food Frequency Questionnaire (indicator of habitual intake), 6 months|Strength, Muscle force measures in 8 muscle groups, 6 months|Nutritional Indices, Pre-Albumin, 6 months
|
